AnalystBook Research · Company Intelligence

REGAL REXNORD CORP

RRXNYSE

Built from REGAL REXNORD CORP's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Regal Rexnord preserved strong free cash flow and improved margin through lower revenue and profit, but a distress-range screen and acquisition-heavy structure kept leverage central.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue declined 1.6%Watch
  • ProfitabilityNet income grew 42.5% to $279.5M from $196.2MOK
  • Cash flowFree cash flow grew 78.7% to $893.1M from $499.9MOK
  • MarginsOperating margin expanded 103 bps to 11.47%OK
  • AccountingCash resilience with leverage contextWatch
  • Insiders0 purchases and 14 salesWatch

Business

Regal Rexnord manufactures motion-control, power-transmission and automation products.

Where the revenue comes from

Fiscal 2025, as REGAL REXNORD CORP reports it. History and quarterly detail are in the app.

  • Industrial Powertrain Solutions$2.6B
  • Automation & Motion Control$1.7B
  • Power Efficiency Solutions$1.7B

Latest filings

  • 8-K · Company announcement2026-08-05
  • 10-Q · Quarterly report2026-08-05
  • 8-K · Company announcement2026-06-01
  • 8-K · Company announcement2026-05-07
  • 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about REGAL REXNORD CORP, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.